SI2318375T1 - Imidazol karboksamidi - Google Patents

Imidazol karboksamidi

Info

Publication number
SI2318375T1
SI2318375T1 SI200930350T SI200930350T SI2318375T1 SI 2318375 T1 SI2318375 T1 SI 2318375T1 SI 200930350 T SI200930350 T SI 200930350T SI 200930350 T SI200930350 T SI 200930350T SI 2318375 T1 SI2318375 T1 SI 2318375T1
Authority
SI
Slovenia
Prior art keywords
imidazole carboxamides
carboxamides
imidazole
Prior art date
Application number
SI200930350T
Other languages
English (en)
Slovenian (sl)
Inventor
Albert Khilevich
Bin Liu
Daniel Ray Mayhugh
Jeffrey Michael Schkeryantz
Deyi Zhang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SI2318375T1 publication Critical patent/SI2318375T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
SI200930350T 2008-07-18 2009-07-14 Imidazol karboksamidi SI2318375T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8177408P 2008-07-18 2008-07-18
PCT/US2009/050440 WO2010009062A1 (en) 2008-07-18 2009-07-14 Imidazole carboxamides
EP09790351A EP2318375B1 (en) 2008-07-18 2009-07-14 Imidazole carboxamides

Publications (1)

Publication Number Publication Date
SI2318375T1 true SI2318375T1 (sl) 2012-11-30

Family

ID=41128155

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930350T SI2318375T1 (sl) 2008-07-18 2009-07-14 Imidazol karboksamidi

Country Status (19)

Country Link
US (1) US7754742B2 (US20070167479A1-20070719-C00034.png)
EP (1) EP2318375B1 (US20070167479A1-20070719-C00034.png)
JP (1) JP5379227B2 (US20070167479A1-20070719-C00034.png)
KR (1) KR101287713B1 (US20070167479A1-20070719-C00034.png)
CN (1) CN102099344B (US20070167479A1-20070719-C00034.png)
AR (1) AR074631A1 (US20070167479A1-20070719-C00034.png)
BR (1) BRPI0915977A2 (US20070167479A1-20070719-C00034.png)
CA (1) CA2731215C (US20070167479A1-20070719-C00034.png)
CY (1) CY1113315T1 (US20070167479A1-20070719-C00034.png)
DK (1) DK2318375T3 (US20070167479A1-20070719-C00034.png)
EA (1) EA018434B1 (US20070167479A1-20070719-C00034.png)
ES (1) ES2393243T3 (US20070167479A1-20070719-C00034.png)
HR (1) HRP20120830T1 (US20070167479A1-20070719-C00034.png)
MX (1) MX2011000611A (US20070167479A1-20070719-C00034.png)
PL (1) PL2318375T3 (US20070167479A1-20070719-C00034.png)
PT (1) PT2318375E (US20070167479A1-20070719-C00034.png)
SI (1) SI2318375T1 (US20070167479A1-20070719-C00034.png)
TW (1) TW201006801A (US20070167479A1-20070719-C00034.png)
WO (1) WO2010009062A1 (US20070167479A1-20070719-C00034.png)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
AU2008297877C1 (en) 2007-09-14 2013-11-07 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
CN101801951B (zh) 2007-09-14 2013-11-13 杨森制药有限公司 1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
JP5656848B2 (ja) 2008-10-16 2015-01-21 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体モジュレーターとしてのインドールおよびベンゾモルホリンの誘導体
ME01573B (me) 2009-05-12 2014-09-20 Addex Pharma Sa DERIVATI 1,2,4-TRIAZOLO[4,3-a]PIRIDINA I NJIHOVA UPOTREBA U TRETMANU ILI PREVENCIJI NEUROLOŠKIH I PSIHIJATRIJSKIH POREMEĆAJA
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MX2011011962A (es) 2009-05-12 2012-02-28 Janssen Pharmaceuticals Inc Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostericos positivos de receptores de glutamato metabotropico (mglur2).
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JP5852666B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
US20150072396A1 (en) 2011-03-04 2015-03-12 Life Technologies Corporation Compounds and Methods for Conjugation of Biomolecules
WO2012131539A1 (en) 2011-03-31 2012-10-04 Pfizer Inc. Novel bicyclic pyridinones
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20200036063A (ko) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
PE20171318A1 (es) 2015-02-03 2017-09-07 Pfizer Ciclopropabenzofuranil-piridopirazindionas novedosas
JP6518789B2 (ja) * 2015-04-23 2019-05-22 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 精神障害の処置において使用するためのテトラゾール誘導体
CN104788694B (zh) * 2015-04-29 2018-06-08 江苏亚宝绝缘材料股份有限公司 一种超低收缩率的聚酰亚胺薄膜
CN108137566B (zh) 2015-10-06 2021-05-25 豪夫迈·罗氏有限公司 三唑衍生物
WO2017133990A1 (en) 2016-02-02 2017-08-10 F. Hoffmann-La Roche Ag Pyrazol-pyridine derivatives as eaat3 inhibitors
EP3464246B1 (en) 2016-05-27 2020-07-08 H. Hoffnabb-La Roche Ag Pyrazol compounds as eaat3 inhibitors
JP7068277B2 (ja) 2016-10-14 2022-05-16 エフ.ホフマン-ラ ロシュ アーゲー Eaat3阻害剤としてのイミダゾール化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI802783A (fi) 1979-09-05 1981-03-06 Glaxo Group Ltd Fenolderivat
US4666928A (en) 1984-08-30 1987-05-19 Merck Frosst Canada, Ind. Propylphenoxy pyridine carboxylates as leukotriene antagonists
TW204343B (US20070167479A1-20070719-C00034.png) 1991-05-31 1993-04-21 Sumitomo Pharmaceutics Co Ltd
EP1255735A2 (en) 2000-02-03 2002-11-13 Eli Lilly And Company Pyridine derivatives as potentiators of glutamate receptors
WO2004018386A2 (en) 2002-08-26 2004-03-04 Merck & Co., Inc. Acetophenone potentiators of metabotropic glutamate receptors
EP1773792A1 (en) 2004-07-30 2007-04-18 Merck & Co., Inc. Indanone potentiators of metabotropic glutamate receptors
JP2008508288A (ja) * 2004-07-30 2008-03-21 メルク エンド カムパニー インコーポレーテッド 代謝調節型グルタミン酸受容体のヘテロ環式アセトフェノン増強剤
TW200613272A (en) 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
EP1807073A2 (en) 2004-10-25 2007-07-18 Merck & Co., Inc. Heterocyclic indanone potentiators of metabotropic glutamate receptors
KR20090006237A (ko) * 2004-11-22 2009-01-14 일라이 릴리 앤드 캄파니 글루타메이트 수용체의 증강제
WO2006071730A1 (en) 2004-12-27 2006-07-06 Astrazeneca Ab Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders
JP2009509921A (ja) 2005-08-12 2009-03-12 アストラゼネカ アクチボラグ 置換イソインドロン類及び代謝調節型グルタミン酸受容体増強剤としてのその使用

Also Published As

Publication number Publication date
EP2318375B1 (en) 2012-09-19
DK2318375T3 (da) 2012-10-08
US7754742B2 (en) 2010-07-13
HRP20120830T1 (hr) 2012-11-30
CN102099344A (zh) 2011-06-15
PL2318375T3 (pl) 2013-02-28
PT2318375E (pt) 2012-10-22
JP2011528658A (ja) 2011-11-24
AU2009271105A1 (en) 2010-01-21
EA018434B1 (ru) 2013-07-30
EP2318375A1 (en) 2011-05-11
BRPI0915977A2 (pt) 2018-10-30
WO2010009062A1 (en) 2010-01-21
JP5379227B2 (ja) 2013-12-25
TW201006801A (en) 2010-02-16
CY1113315T1 (el) 2016-04-13
AR074631A1 (es) 2011-02-02
CN102099344B (zh) 2013-10-30
KR101287713B1 (ko) 2013-07-23
MX2011000611A (es) 2011-03-01
US20100016373A1 (en) 2010-01-21
CA2731215C (en) 2013-08-27
CA2731215A1 (en) 2010-01-21
ES2393243T3 (es) 2012-12-19
EA201170227A1 (ru) 2011-06-30
KR20110022676A (ko) 2011-03-07

Similar Documents

Publication Publication Date Title
PL2318375T3 (pl) Karboksyamidy imidazolu
EP2280616A4 (en) BODY FOR BABY
EP2257170A4 (en) TÉTRAHYDROFUROPYRIDONES
EP2285758A4 (en) DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
EP2313147A4 (en) crimping
GB0801600D0 (en) Microtrench
EP2233305A4 (en) GRAPHIC PRINTER
EP2285375A4 (en) SPIROAZAINDOLE
ZA201102049B (en) Substituted imidazole combinations
GB0820166D0 (en) Former
GB0801589D0 (en) Mollusicide
GB0800389D0 (en) Gileo hang-it
GB0800161D0 (en) Rota-board
AU4098P (en) NPW2 Dianella tasmanica
AU3977P (en) PARV01 Myoporum parvifolium
AU3972P (en) Tobruk xTriticosecale
AU3935P (en) DPV308 Dianella prunina
PL384423A1 (pl) Kołyska
GB0807705D0 (en) Rrocessing line
AU2008306V (en) LND01 Lomandra confertifolia
GB0801979D0 (en) Thermo-pile
GB0800481D0 (en) Mum-brella
GB0801369D0 (en) Argeles
GB0800410D0 (en) Q-Box
AU2008315V (en) DT5001 Dianella tasmanica